Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andraka

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Drug and Alcohol Review|May 13, 2020
Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staffBarbara Andraka-Christou, Danielle Atkins, Jody Madeira, et al.
Foot (Edinburgh, Scotland)|March 5, 2017
The kinetic and kinematic stability measures in healthy adult subjects with and without flat footPaul S Sung, J Timothy Zipple, John M Andraka, et al.
Substance Use & Misuse|April 7, 2023
Legal Limitations Associated with Microdosing BuprenorphineBarbara Andraka-Christou, Matthew Douglas Evans, Beth Tranen, et al.
Health Affairs (Project Hope)|May 1, 2023
Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance Restrictions, 2017-21Barbara Andraka-Christou, Kosali I Simon, W David Bradford, et al.
Psychiatria Danubina|September 22, 2025
THE IMPACT OF CLIMATE CHANGE ON MENTAL HEALTHMagdalena Nowak-Andraka, Wiktor Bednarski, Weronika Siemieniuk, et al.
Substance Abuse|September 7, 2023
Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations ActBrendan Saloner, Barbara Andraka-Christou, Bradley D Stein, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
<i>Chst9</i> Marks a Spatially and Transcriptionally Unique Population of <i>Oprm1</i> -Expressing Neurons in the Nucleus AccumbensEmma Andraka, Robert A Phillips, Kasey L Brida, et al.
Journal of Diabetes Research|November 18, 2015
Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide AmyloidogenesisPhuong Trang Nguyen, Nagore Andraka, Carole Anne De Carufel, et al.
Substance Abuse|April 2, 2021
It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiverBrendan Saloner, Barbara Andraka Christou, Adam J Gordon, et al.
Addiction Neuroscience|July 3, 2024
<i>Chst9</i> marks a spatially and transcriptionally unique population of <i>Oprm1</i>-expressing neurons in the nucleus accumbensEmma Andraka, Robert A Phillips, Kasey L Brida, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Drug and Alcohol Review|May 13, 2020
Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staffBarbara Andraka-Christou, Danielle Atkins, Jody Madeira, et al.
Foot (Edinburgh, Scotland)|March 5, 2017
The kinetic and kinematic stability measures in healthy adult subjects with and without flat footPaul S Sung, J Timothy Zipple, John M Andraka, et al.
Substance Use & Misuse|April 7, 2023
Legal Limitations Associated with Microdosing BuprenorphineBarbara Andraka-Christou, Matthew Douglas Evans, Beth Tranen, et al.
Health Affairs (Project Hope)|May 1, 2023
Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance Restrictions, 2017-21Barbara Andraka-Christou, Kosali I Simon, W David Bradford, et al.
Psychiatria Danubina|September 22, 2025
THE IMPACT OF CLIMATE CHANGE ON MENTAL HEALTHMagdalena Nowak-Andraka, Wiktor Bednarski, Weronika Siemieniuk, et al.
Substance Abuse|September 7, 2023
Will the End of the X-Waiver Expand Access to Buprenorphine Treatment? Achieving the Full Potential of the 2023 Consolidated Appropriations ActBrendan Saloner, Barbara Andraka-Christou, Bradley D Stein, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
<i>Chst9</i> Marks a Spatially and Transcriptionally Unique Population of <i>Oprm1</i> -Expressing Neurons in the Nucleus AccumbensEmma Andraka, Robert A Phillips, Kasey L Brida, et al.
Journal of Diabetes Research|November 18, 2015
Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide AmyloidogenesisPhuong Trang Nguyen, Nagore Andraka, Carole Anne De Carufel, et al.
Substance Abuse|April 2, 2021
It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiverBrendan Saloner, Barbara Andraka Christou, Adam J Gordon, et al.
Addiction Neuroscience|July 3, 2024
<i>Chst9</i> marks a spatially and transcriptionally unique population of <i>Oprm1</i>-expressing neurons in the nucleus accumbensEmma Andraka, Robert A Phillips, Kasey L Brida, et al.
Pageof 14